Article Text
Abstract
Despite concerns about the relationships between health professionals and the medical device industry, the issue has received relatively little attention. Prevalence data are lacking; however, qualitative and survey research suggest device industry representatives, who are commonly present in clinical settings, play a key role in these relationships. Representatives, who are technical product specialists and not necessarily medically trained, may attend surgeries on a daily basis and be available to health professionals 24 hours a day, 7 days a week, to provide advice. However, device representatives have a dual role: functioning as commissioned sales representatives at the same time as providing advice on approaches to treatment. This duality raises the concern that clinical decision-making may be unduly influenced by commercial imperatives. In this paper, we identify three key ethical concerns raised by the relationship between device representatives and health professionals: (1) impacts on healthcare costs, (2) the outsourcing of expertise and (3) issues of accountability and informed consent. These ethical concerns can be addressed in part through clarifying the boundary between the support and sales aspects of the roles of device representatives and developing clear guidelines for device representatives providing support in clinical spaces. We suggest several policy options including hospital provision of expert support, formalising clinician conduct to eschew receipt of meals and payments from industry and establishing device registries.
- health care economics
- informed consent
- professional - professional relationship
- surgery
- technology/risk assessment
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Long - term follow - up of older patients with Mobitz type I second degree atrioventricular block
- Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis
- Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition
- Contemporary management of cardiac implantable electronic device infection
- Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection
- Cardiac implantable electronic devices in adults with tetralogy of Fallot
- MRI for patients with cardiac implantable electronic devices: simplifying complexity with a ‘ one - stop ’ service model
- Safety of serial MRI in patients with implantable cardioverter defibrillators
- Long - term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study
- Successful conservative management of a permanent pacemaker pocket infection: a less invasive approach